STOCK TITAN
  1. Home
  2. Sec-filings
  3. XRAY
  4. [Form 4] DENTSPLY SIRONA Inc. Insider Trading Activity

DENTSPLY SIRONA (XRAY) CEO granted 3,554 phantom stock units in SERP

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Scavilla Daniel T reported acquisition or exercise transactions in this Form 4 filing.

DENTSPLY SIRONA Inc. reported that President and CEO Daniel T. Scavilla received a grant of 3,554.869 shares of phantom stock under a Supplemental Executive Retirement Plan. The phantom stock has an economic value equivalent to common stock at a reference price of $11.43 per share.

The award represents a SERP contribution for the year 2025 based on the 12/31/25 closing price and is held as a derivative interest. These phantom shares will be settled in common stock upon the executive’s termination of employment, and there were 3,554.869 phantom stock units reported as held directly after this grant.

Positive

  • None.

Negative

  • None.
Insider Scavilla Daniel T
Role President, CEO & Member of BOD
Type Security Shares Price Value
Grant/Award Phantom Stock (Supplemental Executive Retirement Plan) SERP 3,554.869 $11.43 $41K
Holdings After Transaction: Phantom Stock (Supplemental Executive Retirement Plan) SERP — 3,554.869 shares (Direct)
Footnotes (3)
  1. F1. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of employment.
  2. F2. Comprised of phantom stock.
  3. F3. Supplemental Executive Retirement Plan (SERP) contribution for the year 2025 based on 12/31/25 closing price.

FAQ

What did DENTSPLY SIRONA (XRAY) CEO Daniel Scavilla report in this Form 4?
Daniel Scavilla reported receiving 3,554.869 phantom stock units as a compensation grant. These units are part of a Supplemental Executive Retirement Plan and track the value of common stock, enhancing his long-term, equity-linked retirement benefits with the company.

What is the value basis of the phantom stock granted to XRAY’s CEO?
The phantom stock grant to XRAY’s CEO is based on a reference price of $11.43 per unit. This price reflects the 12/31/25 closing price and determines the number of phantom shares credited as the 2025 Supplemental Executive Retirement Plan contribution.

How does the phantom stock for DENTSPLY SIRONA’s CEO convert into common shares?
Each phantom stock unit is economically equivalent to one share of common stock. According to the filing, the phantom stock becomes payable in common stock upon Daniel Scavilla’s termination of employment, turning his deferred compensation into actual equity at that time.

Is the XRAY CEO’s phantom stock grant an open-market stock purchase or sale?
No, the phantom stock grant is a compensation-related award, not an open-market trade. It reflects a Supplemental Executive Retirement Plan contribution and results in 3,554.869 phantom units, rather than a direct market purchase or sale of XRAY common shares.

How many phantom stock units does XRAY’s CEO hold after this reported transaction?
After this transaction, Daniel Scavilla is reported to hold 3,554.869 phantom stock units directly. These units mirror the value of common stock and will eventually be settled in actual shares when his employment with DENTSPLY SIRONA ends.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Scavilla Daniel T
(Last) (First) (Middle)
C/O DENTSPLY SIRONA INC
13320-B BALLANTYNE CORPORATE PLACE
(Street)
CHARLOTTE NC 28277
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President, CEO & Member of BOD
3. Date of Earliest Transaction (Month/Day/Year)
03/11/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Phantom Stock (Supplemental Executive Retirement Plan) SERP (1) 03/11/2026 A 3,554.869(2) (1) (1) Common Stock 3,554.869 $11.43(3) 3,554.869 D
Explanation of Responses:
1. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of employment.
2. Comprised of phantom stock.
3. Supplemental Executive Retirement Plan (SERP) contribution for the year 2025 based on 12/31/25 closing price.
/s/ Jessica Nielsen Causey, Attorney-in-Fact for Daniel T. Scavilla 03/12/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR